Viking Global Opportunities Parent GP LLC

10% OwnerInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Oct 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.3M
Net Open-Market Flow
-$11.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Sell(S)16K$32.25$526K67K
Oct 7, 2025Sell(S)309K$32.25$10.0M1.3M
Oct 7, 2025Sell(S)25K$32.25$808K103K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-003555) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about INBX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000905148-25-003555"
Ask your agent
Use Arkolith to summarize insider buying and selling at Inhibrx Biosciences, Inc.
over the last 90 days and cite the filings.